Although the hazard ratio of any bleeding and major bleeding suggest benefit in the subgroup of women, the p -value did not reach statistical significance.
← all excerpts
Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome?
2
—
—
The sentences
In aggregate, a clear trend to a higher incidence of ischemic complications has been consistently reported in women.